Pentraxin 3 genotyping in relation to serum levels of pentraxin 3 in patients with acute ST-segment elevation myocardial infarction
Clinical Trials and Regulatory Science in Cardiology · 2016
DOI: 10.1016/j.ctrsc.2015.11.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2016. Verfasst von Ehab K. El Melegy und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Melegy, E. K. E., Badr, E. A., ElKersh, A. M., Shafey, W. H. E., & Fareed, W. A. (2016). Pentraxin 3 genotyping in relation to serum levels of pentraxin 3 in patients with acute ST-segment elevation myocardial infarction. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.11.002
Vancouver
Melegy EKE, Badr EA, ElKersh AM, Shafey WHE, Fareed WA. Pentraxin 3 genotyping in relation to serum levels of pentraxin 3 in patients with acute ST-segment elevation myocardial infarction. Clinical Trials and Regulatory Science in Cardiology. 2016. doi:10.1016/j.ctrsc.2015.11.002
BibTeX
@article{Melegy2016,
author = {Melegy, Ehab K. El and Badr, Eman A. and ElKersh, Ahmed M. and Shafey, Wassam H. EL and Fareed, Walaa A.},
title = {Pentraxin 3 genotyping in relation to serum levels of pentraxin 3 in patients with acute ST-segment elevation myocardial infarction},
journal = {Clinical Trials and Regulatory Science in Cardiology},
year = {2016},
doi = {10.1016/j.ctrsc.2015.11.002}
}
EUVIMED